Login / Signup

Review and evaluation of vancomycin dosing guidelines for obese individuals.

Sherilyn WongStephanie E ReuterGraham R D JonesSophie Lena Stocker
Published in: Expert opinion on drug metabolism & toxicology (2022)
Vancomycin pharmacokinetics in obese individuals remains debated. Guidelines that determine loading doses using total body weight, and maintenance doses adjusted based on renal function and adjusted body weight, may be most appropriate for obese individuals. Use of ideal body weight leads to subtherapeutic vancomycin exposure and underestimation of renal function.
Keyphrases
  • body weight
  • adipose tissue
  • weight loss
  • methicillin resistant staphylococcus aureus
  • metabolic syndrome
  • type diabetes
  • obese patients
  • clinical practice
  • bariatric surgery